Immune Checkpoint Inhibitors: Altering the Landscape of Treatment in Hepatobiliary Cancers

Gain insight into the emerging use of immunotherapy in the treatment of hepatobiliary cancers including HCC and BTCs with an expert-presented webcast and downloadable slidesets.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca